Equities

Hiwin Technologies Corp

Hiwin Technologies Corp

Actions
  • Price (USD)0.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HIWIN TECHNOLOGIES CORP. is a Taiwan-based company mainly engaged in the research, development, design, manufacture, sale and repair of linear guide ways (GWs), ball screws (BSs) , industrial robots, precision bearings, rotary tables, medical equipment and semiconductor equipment. The products are applied in industrial equipment, life sciences equipment, medical equipment, automation equipment, electronic equipment, optical and semiconductor equipment. The Company distributes its products in domestic market and to overseas markets, including Germany, Japan and United States.

  • Revenue in TWD (TTM)24.41bn
  • Net income in TWD1.99bn
  • Incorporated1989
  • Employees3.70k
  • Location
    Hiwin Technologies CorpNo. 7,Jingke Road, Nantun DistrictTAICHUNG 408TaiwanTWN
  • Phone+886 423594510
  • Fax+886 423594420
  • Websitehttps://www.hiwin.tw/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.